Clegg C H, Correll L A, Cadd G G, McKnight G S
Department of Pharmacology, University of Washington, Seattle 98195.
J Biol Chem. 1987 Sep 25;262(27):13111-9.
Expression vectors were constructed that code for mutated forms of the regulatory type 1 subunit (RI) of cyclic AMP-dependent protein kinase. These mutations alter a specific amino acid which is present in each of two homologous cAMP-binding domains of the RI protein. When these expression vectors were introduced into NIH 3T3 and Y1 adrenocortical tumor cells a mutant RI protein was produced that acted in a dominant fashion to cause a 20-400-fold inhibition of cAMP-dependent protein kinase activation. In addition, processes controlled by cAMP in adrenal cells were blocked; cells became resistant to the growth-inhibitory effects of cAMP and defective in steroid synthesis. Expression of mutant RI genes in cells provides a specific means to explore the role of cAMP and protein phosphorylation in the process of intracellular signalling.
构建了编码环磷酸腺苷(cAMP)依赖性蛋白激酶调节1型亚基(RI)突变形式的表达载体。这些突变改变了RI蛋白两个同源cAMP结合结构域中每个结构域都存在的一个特定氨基酸。当将这些表达载体导入NIH 3T3和Y1肾上腺皮质肿瘤细胞时,产生了一种突变RI蛋白,该蛋白以显性方式发挥作用,导致cAMP依赖性蛋白激酶激活受到20至400倍的抑制。此外,肾上腺细胞中由cAMP控制的过程被阻断;细胞对cAMP的生长抑制作用产生抗性,并且类固醇合成存在缺陷。在细胞中表达突变RI基因提供了一种探索cAMP和蛋白磷酸化在细胞内信号传导过程中作用的特定方法。